Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Neuroethics for the National Institutes of Health BRAIN Initiative.

Bianchi DW, Cooper JA, Gordon JA, Heemskerk J, Hodes R, Koob GF, Koroshetz WJ, Shurtleff D, Sieving PA, Volkow ND, Churchill JD, Ramos KM.

J Neurosci. 2018 Dec 12;38(50):10583-10585. doi: 10.1523/JNEUROSCI.2091-18.2018. No abstract available.

2.

Acupuncture and Sham Acupuncture for Pain Relief-Reply.

Briggs JP, Shurtleff D.

JAMA. 2017 Oct 17;318(15):1503. doi: 10.1001/jama.2017.13398. No abstract available.

PMID:
29049651
3.

Acupuncture and the Complex Connections Between the Mind and the Body.

Briggs JP, Shurtleff D.

JAMA. 2017 Jun 27;317(24):2489-2490. doi: 10.1001/jama.2017.7214. No abstract available.

PMID:
28654992
4.

National Institutes of Health Research Plan on Rehabilitation: NIH Medical Rehabilitation Coordinating Committee.

NIH Medical Rehabilitation Coordinating Committee, O'Mara A, Rowland JH, Greenwell TN, Wiggs CL, Fleg J, Joseph L, McGowan J, Panagis JS, Washabaugh C, Peng GCY, Bray R, Cernich AN, Cruz TH, Marden S, Michel ME, Nitkin R, Quatrano L, Spong CY, Shekim L, Jones TLZ, Juliano-Bult D, Panchinson DM, Chen D, Jakeman L, Knebel A, Tully LA, Chan L, Damiano D, Tian B, McInnes P, Khalsa P, Reider E, Shurtleff D, Elwood W, Ballard R, Ershow AG, Begg L.

Phys Ther. 2017 Apr 1;97(4):104-407. doi: 10.1093/ptj/pzx026.

5.

Reevaluating the placebo effect in medical practice.

Colloca L, Jonas WB, Killen J, Miller FG, Shurtleff D.

Z Psychol. 2014;222(3):124-127. doi: 10.1027/2151-2604/a000177.

6.

Neuroimmune mechanisms of alcohol and drug addiction.

Cui C, Shurtleff D, Harris RA.

Int Rev Neurobiol. 2014;118:1-12. doi: 10.1016/B978-0-12-801284-0.00001-4. Review.

7.

Sponsor's foreword: NIDA at forty.

Shurtleff D, Sasek C, Kautz M.

Neuropharmacology. 2014 Jan;76 Pt B:195-7. doi: 10.1016/j.neuropharm.2013.08.020. Epub 2013 Aug 28. No abstract available.

PMID:
23994442
8.

Reinnervating the penis in spina bifida patients in the United States: ilioinguinal-to-dorsal-penile neurorrhaphy in two cases.

Jacobs MA, Avellino AM, Shurtleff D, Lendvay TS.

J Sex Med. 2013 Oct;10(10):2593-7. doi: 10.1111/jsm.12255. Epub 2013 Jul 11.

PMID:
23844557
9.

HIV and substance abuse: a commentary.

Shurtleff D, Lawrence D.

Curr HIV Res. 2012 Jul;10(5):366-8. No abstract available.

PMID:
22591360
10.

Nonprogrammable and programmable cerebrospinal fluid shunt valves: a 5-year study.

Hatlen TJ, Shurtleff DB, Loeser JD, Ojemann JG, Avellino AM, Ellenbogen RG.

J Neurosurg Pediatr. 2012 May;9(5):462-7. doi: 10.3171/2012.1.PEDS10482.

PMID:
22546022
11.

Do opioids activate latent HIV-1 by down-regulating anti-HIV microRNAs?

Purohit V, Rapaka RS, Rutter J, Shurtleff D.

J Neuroimmune Pharmacol. 2012 Sep;7(3):519-23. doi: 10.1007/s11481-012-9356-1. Epub 2012 Apr 17. Review.

PMID:
22527633
12.

Fetal endoscopic myelomeningocele repair.

Shurtleff D.

Dev Med Child Neurol. 2012 Jan;54(1):4-5. doi: 10.1111/j.1469-8749.2011.04141.x. Epub 2011 Nov 29. No abstract available.

13.

Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.

Purohit V, Rapaka R, Shurtleff D.

Mol Neurobiol. 2011 Aug;44(1):102-10. doi: 10.1007/s12035-011-8195-z. Epub 2011 Jul 1. Review.

PMID:
21717292
14.

Potential impact of drugs of abuse on mother-to-child transmission (MTCT) of HIV in the era of highly active antiretroviral therapy (HAART).

Purohit V, Rapaka RS, Schnur P, Shurtleff D.

Life Sci. 2011 May 23;88(21-22):909-16. doi: 10.1016/j.lfs.2011.03.022. Epub 2011 Apr 6.

PMID:
21477599
15.

Obesity and myelomeningocele: anthropometric measures.

Shurtleff DB, Walker WO, Duguay S, Peterson D, Cardenas D.

J Spinal Cord Med. 2010;33(4):410-9.

16.

Mother-to-child transmission (MTCT) of HIV and drugs of abuse in post-highly active antiretroviral therapy (HAART) era.

Purohit V, Rapaka RS, Shurtleff D.

J Neuroimmune Pharmacol. 2010 Dec;5(4):507-15. doi: 10.1007/s11481-010-9242-7. Epub 2010 Sep 14. Review.

PMID:
20838913
17.

Contributory factors to postoperative spinal fusion complications for children with myelomeningocele.

Hatlen T, Song K, Shurtleff D, Duguay S.

Spine (Phila Pa 1976). 2010 Jun 1;35(13):1294-9. doi: 10.1097/BRS.0b013e3181bf8efe.

PMID:
20354477
18.

Role of cannabinoids in the development of fatty liver (steatosis).

Purohit V, Rapaka R, Shurtleff D.

AAPS J. 2010 Jun;12(2):233-7. doi: 10.1208/s12248-010-9178-0. Epub 2010 Mar 5. Review.

19.

Haemophilus influenzae and Streptococcus pneumoniae infections in children with cerebrospinal fluid shunts.

Shurtleff DB, Loeser JD, Avellino AM, Duguay S, Englund JA, Marcuse EK, Peterson D.

Pediatr Neurosurg. 2009;45(4):276-80. doi: 10.1159/000228986. Epub 2009 Jul 17.

PMID:
19609096
20.

Seminars in Cell & Developmental Biology. The molecular and cellular mechanisms in the development of addiction. Editorial.

Wu DY, Pollock JD, Shurtleff D.

Semin Cell Dev Biol. 2009 Jun;20(4):377. doi: 10.1016/j.semcdb.2009.03.002. Epub 2009 Mar 13. No abstract available.

PMID:
19560041
21.

Treatments for nicotine addiction should be a top priority.

Pollock JD, Koustova E, Hoffman A, Shurtleff D, Volkow ND.

Lancet. 2009 Aug 15;374(9689):513-4. doi: 10.1016/S0140-6736(09)60352-4. Epub 2009 Apr 24. No abstract available.

22.

One SNP linked to two diseases-addiction and cancer: a double whammy? Nicotine addiction and lung cancer susceptibility.

Volkow N, Rutter J, Pollock JD, Shurtleff D, Baler R.

Mol Psychiatry. 2008 Nov;13(11):990-2. doi: 10.1038/mp.2008.71. Epub 2008 Jul 1. Review. No abstract available.

23.

Frontiers in addiction research: celebrating the 35th anniversary of the National Institute on Drug Abuse. Sponsor's foreword.

Shurtleff D, Liu R, Sasek C.

Neuropharmacology. 2009;56 Suppl 1:1-2. doi: 10.1016/j.neuropharm.2008.08.009. Epub 2008 Aug 19. No abstract available.

PMID:
18789343
24.

Obesity and addiction: common neurological mechanisms and drug development.

Rapaka R, Schnur P, Shurtleff D.

Physiol Behav. 2008 Sep 3;95(1-2):2-9. doi: 10.1016/j.physbeh.2008.05.001. Epub 2008 May 9. Review. No abstract available.

PMID:
18571681
25.

NIDA drug supply and analytical services program: providing research resources and tools to the scientific community.

Singh HH, Rapaka RS, Shurtleff D, De La Garza R.

Drug Alcohol Depend. 2008 May 1;95(1-2):182-6. No abstract available.

PMID:
18484110
26.

Social neuroscience: applications to addiction.

Schnur P, Shurtleff D.

Drug Alcohol Depend. 2008 Apr 1;94(1-3):285-90. No abstract available.

PMID:
18444276
27.

Psychoneuroendocrine effects of combined thyroxine and triiodothyronine versus tyrosine during prolonged Antarctic residence.

Palinkas LA, Reedy KR, Smith M, Anghel M, Steel GD, Reeves D, Shurtleff D, Case HS, Van Do N, Reed HL.

Int J Circumpolar Health. 2007 Dec;66(5):401-17.

PMID:
18274206
28.

The nuts and bolts of gene array technology and its application to drug abuse research.

Shurtleff D, Rutter JL, Ramsey KE, Craig DW, Stephan DA.

Drug Alcohol Depend. 2007 Nov 2;91(1):102-6. No abstract available.

PMID:
17977095
29.

Sponsor's Foreword.

Shurtleff D, Ferré S.

ScientificWorldJournal. 2007 Nov 2;7:1-3. doi: 10.1100/tsw.2007.222. eCollection 2007. No abstract available.

30.

Pediatric perspective on prenatal counseling for myelomeningocele.

Doherty D, Shurtleff DB.

Birth Defects Res A Clin Mol Teratol. 2006 Sep;76(9):645-53. Review.

PMID:
17001678
31.

Acquisition of autonomy skills in adolescents with myelomeningocele.

Davis BE, Shurtleff DB, Walker WO, Seidel KD, Duguay S.

Dev Med Child Neurol. 2006 Apr;48(4):253-8.

32.

Long-term survival of individuals with myelomeningocele.

Davis BE, Daley CM, Shurtleff DB, Duguay S, Seidel K, Loeser JD, Ellenbogan RG.

Pediatr Neurosurg. 2005 Jul-Aug;41(4):186-91.

PMID:
16088253
33.

Epidemiology of neural tube defects and folic acid.

Shurtleff DB.

Cerebrospinal Fluid Res. 2004 Dec 10;1(1):5.

34.

Setting priorities for genomic research.

Berrettini W, Bierut L, Crowley TJ, Cubells JF, Frascella J, Gelernter J, Hewitt JK, Kreek MJ, Lachman H, Leppert M, Li MD, Madden P, Miner C, Pollock JD, Pomerleau O, Rice JP, Rutter JL, Shurtleff D, Swan GE, Tischfield JA, Tsuang M, Uhl GR, Vanyukov M, Volkow ND, Wanke K.

Science. 2004 Jun 4;304(5676):1445-7; author reply 1445-7. No abstract available.

PMID:
15178784
35.
36.

Longevity of patients born with myelomeningocele.

Dillon CM, Davis BE, Duguay S, Seidel KD, Shurtleff DB.

Eur J Pediatr Surg. 2000 Dec;10 Suppl 1:33-4.

PMID:
11214830
37.

A behavioral economic analysis of the relative persistence of behavior: comment on Meisch (2000)

Shurtleff D.

Exp Clin Psychopharmacol. 2000 Aug;8(3):357-9; discussion 362-5.

PMID:
10975625
38.

Normal growth of the spinal cord.

Moskowitz D, Weinberger E, Shurtleff DB.

Eur J Pediatr Surg. 1999 Dec;9 Suppl 1:48-9. No abstract available.

PMID:
10661800
39.

19-year follow-up of fetal myelomeningocele brought to term.

Liu SL, Shurtleff DB, Ellenbogen RG, Loeser JD, Kropp R.

Eur J Pediatr Surg. 1999 Dec;9 Suppl 1:12-4.

PMID:
10661783
40.

Anatomy of the spinal cord in patients with meningomyelocele with and without hypoplasia or hydromyelia.

Moskowitz D, Shurtleff DB, Weinberger E, Loeser J, Ellenbogen R.

Eur J Pediatr Surg. 1998 Dec;8 Suppl 1:18-21.

PMID:
9926318
41.

Epidemiology of tethered cord with meningomyelocele.

Shurtleff DB, Duguay S, Duguay G, Moskowitz D, Weinberger E, Roberts T, Loeser J.

Eur J Pediatr Surg. 1997 Dec;7 Suppl 1:7-11. Review.

PMID:
9497108
42.

Vertebral column and spinal cord malformation in children with exstrophy of the cloaca, with emphasis on their functional correlates.

Weaver KB, Matthews H, Chegini S, King H, Shurtleff DB, McLaughlin JF.

Teratology. 1997 Apr;55(4):241-8.

PMID:
9216041
43.

Plasma homocysteine and methionine concentrations in children with neural tube defects.

Graf WD, Oleinik OE, Jack RM, Eder DN, Shurtleff DB.

Eur J Pediatr Surg. 1996 Dec;6 Suppl 1:7-9.

PMID:
9008810
44.

Substitution and caloric regulation in a closed economy.

Bauman RA, Raslear TG, Hursh SR, Shurtleff D, Simmons L.

J Exp Anal Behav. 1996 Mar;65(2):401-22.

45.

Comparison of erythrocyte antioxidant enzyme activities and embryologic level of neural tube defects.

Graf WD, Oleinik OE, Pippenger CE, Eder DN, Glauser TA, Shurtleff DB.

Eur J Pediatr Surg. 1995 Dec;5 Suppl 1:8-11.

PMID:
8770569
46.

Erythrocyte antioxidant enzyme activities in children with myelomeningocele.

Graf WD, Pippenger CE, Shurtleff DB.

Dev Med Child Neurol. 1995 Oct;37(10):900-5.

PMID:
7493723
47.

Epidemiology, etiologic factors, and prenatal diagnosis of open spinal dysraphism.

Shurtleff DB, Lemire RJ.

Neurosurg Clin N Am. 1995 Apr;6(2):183-93. Review.

PMID:
7620346
48.

Fetal aqueductal stenosis diagnosed sonographically: how grave is the prognosis?

Levitsky DB, Mack LA, Nyberg DA, Shurtleff DB, Shields LA, Nghiem HV, Cyr DR.

AJR Am J Roentgenol. 1995 Mar;164(3):725-30.

PMID:
7863902
49.

The outcome of fetal myelomeningocele brought to term.

Shurtleff DB, Luthy DA, Nyberg DA, Mack LA.

Eur J Pediatr Surg. 1994 Dec;4 Suppl 1:25-8.

PMID:
7766548
50.

Tyrosine reverses a cold-induced working memory deficit in humans.

Shurtleff D, Thomas JR, Schrot J, Kowalski K, Harford R.

Pharmacol Biochem Behav. 1994 Apr;47(4):935-41.

PMID:
8029265

Supplemental Content

Loading ...
Support Center